Yu Zhang

8PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosisMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Sep 24, 2020
Prognostic role of aberrant mTOR activation in patients with stage II and III colorectal cancer.

Tong-Tong Zhang, Yi-Qing Zhu, Hong-Qing Cai

|Aug 08, 2018
ANXA2 promotes esophageal cancer progression by activating MYC-HIF1A-VEGF axis.

Sai Ma, Chen-Chen Lu, Li-Yan Yang

|Jul 01, 2018
Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.

Ting-Ting Liu, Kai-Xia Yang, Jing Yu

Pageof 2